INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 132 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2016. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,184,000 | -0.9% | 144,713 | +0.1% | 0.00% | 0.0% |
| Q3 2016 | $2,203,000 | -71.4% | 144,534 | -27.2% | 0.00% | -70.0% |
| Q2 2016 | $7,712,000 | +65.5% | 198,655 | +18.5% | 0.01% | +66.7% |
| Q1 2016 | $4,659,000 | -44.5% | 167,595 | +7.3% | 0.01% | -45.5% |
| Q4 2015 | $8,399,000 | +44.0% | 156,141 | +7.2% | 0.01% | +37.5% |
| Q3 2015 | $5,831,000 | +51.3% | 145,639 | +20.8% | 0.01% | +60.0% |
| Q2 2015 | $3,853,000 | +27.7% | 120,602 | -4.5% | 0.01% | +25.0% |
| Q1 2015 | $3,017,000 | +56.2% | 126,321 | +15.5% | 0.00% | +33.3% |
| Q4 2014 | $1,931,000 | +28.1% | 109,390 | -0.5% | 0.00% | +50.0% |
| Q3 2014 | $1,507,000 | -17.9% | 109,955 | +1.0% | 0.00% | 0.0% |
| Q2 2014 | $1,836,000 | – | 108,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
| Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
| SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
| RA Capital Management | 314,349 | $12,587,000 | 1.81% |
| WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
| Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
| Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
| EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
| Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
| WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |